AMY COOKSEY: Open Payments
NPI 1225480304 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 10 payments from 6 companies in 2025. Trend: 2023 $223 · 2024 $261 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| PFIZER INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
Products named: REPATHA, CAMZYOS, ELIQUIS, LEQVIO, JARDIANCE, CLEVIPREX.
Industry payments across AL — which companies pay providers there.
